ThermoGenesis (NASDAQ:THMO – Get Free Report) will be posting its quarterly earnings results after the market closes on Monday, November 13th. Analysts expect ThermoGenesis to post earnings of ($0.21) per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link.
ThermoGenesis (NASDAQ:THMO – Get Free Report) last posted its quarterly earnings results on Thursday, August 10th. The company reported ($0.91) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.01 by ($0.92). The business had revenue of $2.27 million during the quarter, compared to analyst estimates of $4.57 million. ThermoGenesis had a negative return on equity of 365.72% and a negative net margin of 145.48%. On average, analysts expect ThermoGenesis to post $-3 EPS for the current fiscal year and $0 EPS for the next fiscal year.
ThermoGenesis Stock Down 1.9 %
Shares of ThermoGenesis stock opened at $1.03 on Friday. ThermoGenesis has a 12-month low of $0.90 and a 12-month high of $6.75. The stock’s fifty day moving average is $1.15 and its 200-day moving average is $1.34.
Institutional Investors Weigh In On ThermoGenesis
Wall Street Analysts Forecast Growth
Separately, HC Wainwright restated a “buy” rating and issued a $5.00 target price on shares of ThermoGenesis in a report on Friday, August 11th.
ThermoGenesis Holdings, Inc develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market.
- Five stocks we like better than ThermoGenesis
- How to Choose Top Rated Stocks
- Data giants MongoDB and Snowflake just got upgraded
- How to Invest in Small Cap Stocks
- Plug Power at tipping point; it’s make or break time for hydrogen
- Where Do I Find 52-Week Highs and Lows?
- Palantir’s Q3 earnings beat: Time to buy despite analyst caution?
Receive News & Ratings for ThermoGenesis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ThermoGenesis and related companies with MarketBeat.com's FREE daily email newsletter.